Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Future prospects for vaccine adjuvants.

H S Warren¹, L A Chedid

¹Experimental Immunotherapy, Institut Pasteur, Paris, France.

Critical Reviews in Immunology

|January 1, 1988

Summary

New vaccine technologies require adjuvants to boost immune responses. This review explores immunopotentiating agents and strategies for developing safer, more effective vaccines.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Intestinal alkaline phosphatase preserves the normal homeostasis of gut microbiota.

Gut·2010

Same author

Outer membrane protein A (OmpA), peptidoglycan-associated lipoprotein (PAL), and murein lipoprotein (MLP) are released in experimental Gram-negative sepsis.

Journal of endotoxin research·2001

Same author

Biphasic response of NK cells expressing both activating and inhibitory killer Ig-like receptors.

International immunology·2001

Same author

Active immunization with a detoxified Escherichia coli J5 lipopolysaccharide group B meningococcal outer membrane protein complex vaccine protects animals from experimental sepsis.

The Journal of infectious diseases·2001

Same author

CD56.

Journal of biological regulators and homeostatic agents·2001

Same author

CD57.

Journal of biological regulators and homeostatic agents·2001

Area of Science:

Immunology
Vaccinology
Biotechnology

Background:

Historical attempts to enhance vaccine efficacy date back 60 years.
Modern recombinant and synthetic antigens are less immunogenic, necessitating adjuvants.
Advances in biotechnology and immunology have shifted adjuvant research from empirical to developmental.

Purpose of the Study:

To review current immunopotentiating agents.
To discuss strategies for utilizing adjuvants in future vaccine development.

Main Methods:

Literature review of immunopotentiation agents.
Analysis of technological advances in antigen and adjuvant development.
Discussion of immune system understanding.

Main Results:

Adjuvants are crucial for achieving protective immunity with novel antigens.
The field of adjuvant research has become more sophisticated and developmental.
Various agents capable of immunopotentiation are known.

Conclusions:

Future vaccines will likely rely on adjuvants to enhance immunogenicity.
Understanding immune system mechanisms is key to rational adjuvant design.
Developing clinically acceptable adjuvants is essential for next-generation vaccines.

Related Experiment Videos